IGF1 and cervical carcinoma: The earliest studies about the role of miRNA in cervical cancer drug resistance date back to 2012 when miR-145 was identified as a part of a p53-miR-145 axis regulating the IGF signaling pathway responsible for mitomycin resistance in cervical cancer [37].